Collplant Biotechnologies Ltd
NASDAQ:CLGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
IL |
|
A
|
Ardelyx Inc
SWB:41X
|
US |
|
Antilles Gold Ltd
ASX:AAU
|
AU |
|
Koc Holding AS
OTC:KHOLY
|
TR |
|
F
|
Forgent Power Solutions, Inc
NYSE:FPS
|
US |
|
ZTO Express (Cayman) Inc
OTC:ZTOEF
|
CN |
|
Grupa Azoty SA
F:5PL
|
PL |
|
MAP Aktif Adiperkasa Tbk PT
F:JN4
|
ID |
|
Entra ASA
OTC:ENTOF
|
NO |
|
MultiChoice Group Ltd
F:30R
|
ZA |
|
F
|
FutureFuel Corp
F:3FF
|
US |
|
Employers Holdings Inc
NYSE:EIG
|
US |
|
E
|
Espey MFG & Electronics Corp
AMEX:ESP
|
US |
|
N
|
Nel ASA
DUS:D7G
|
NO |
|
P
|
Penumbra Inc
F:0P8
|
US |
|
C
|
CRH PLC
XMUN:CRG
|
IE |
|
Seatrium Limited
F:S8N
|
SG |
|
T
|
Taokaenoi Food & Marketing PCL
SET:TKN
|
TH |
|
B
|
BHG Group AB
LSE:0SOM
|
SE |
Wall St Price Targets
CLGN Price Targets Summary
Collplant Biotechnologies Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CLGN's stock price target?
Not Available
CLGN does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Collplant Biotechnologies Ltd?
Projected CAGR
103%
Over the last 6 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 3 years is 103%.
What is the Gross Profit forecast for Collplant Biotechnologies Ltd?
Projected CAGR
125%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 25%. The projected CAGR for the next 3 years is 125%.